TIPS plus sequential systemic therapy shows promise in advanced HCC with tumor thrombus-related SPHMay 17, 2022Hepatocellular Carcinoma
HCC incidence after successful DAA therapy for hepatitis C varies with cirrhosis statusMay 17, 2022Hepatocellular Carcinoma
Efficacy and safety of tumor vaccines in HCC: Lessons from two decades of researchMay 17, 2022Hepatocellular Carcinoma
Advanced HCC: Lenvatinib plus nivolumab yields promising results in real-world May 17, 2022Hepatocellular Carcinoma
Laparoscopic anatomic hepatectomy achieves better follow-up outcomes than non-anatomical hepatectomy in HCCMay 17, 2022Hepatocellular Carcinoma
Does imaging surveillance intensity govern clinical outcomes in HCC?May 17, 2022Hepatocellular Carcinoma
Subsequent anticancer therapy after ICI treatment prolongs survival in HCCMay 17, 2022Hepatocellular Carcinoma
Pembrolizumab monotherapy shows promise for untreated advanced HCC in phase 2May 17, 2022Hepatocellular Carcinoma
Early-stage HCC: OLT offers better survival outcomes than ablative therapies in the elderlyMay 17, 2022Hepatocellular Carcinoma
Psychosocial Barriers and Their Impact on Hepatocellular Carcinoma Care in US Veterans: Tumor Board Model of CareMay 16, 2022Hepatocellular CarcinomaOncology
TACE vs. LR: Better prognosis in HCC with bile duct tumor thrombus?April 26, 2022Hepatocellular Carcinoma
TACE is safe and effective in elderly patients with intermediate HCCApril 26, 2022Hepatocellular Carcinoma
